Addiction is a brain disorder characterized by compulsive engagement in rewarding stimuli despite adverse consequences.Despite the involvement of a number of psychosocial factors, a biological process – one which is induced by repeated exposure to an addictive stimulus – is the core pathology that drives the development and maintenance of an addiction.
With the rising alcohol, opioid, and tobacco addiction across the world, many public, private, and government organizations are conducting programs to increase awareness about substance abuse and its health implications. For instance, the Substance Abuse and Mental Health Services Administration (SAMHSA) in the US sponsors the Recovery Month to increase awareness about mental and substance use disorders and celebrate recovery. The organization also offers services to people with substance use disorders. Also, in countries such as India, government bodies provide financial assistance to many NGOs and urban local agencies to carry out combines services to spread awareness and rehabilitate individuals with addiction disorders.
Market Analysis and Insights: Global Addictions Therapeutics Market
The research report studies the Addictions Therapeutics market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Addictions Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Addictions Therapeutics Scope and Segment
The global Addictions Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Addictions Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Alcohol Addiction Therapeutics
Tobacco Addiction Therapeutics
Drug Addiction Therapeutics
by Application, this report covers the following segments
Public
Private
Government
Global Addictions Therapeutics market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Addictions Therapeutics key players in this market include:
Alkermes Plc
Amneal Pharmaceuticals Inc.
Indivior Plc
Johnson & Johnson Services Inc.
Mylan NV
Novartis AG
Novo Nordisk AS
Opiant Pharmaceuticals Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
With the rising alcohol, opioid, and tobacco addiction across the world, many public, private, and government organizations are conducting programs to increase awareness about substance abuse and its health implications. For instance, the Substance Abuse and Mental Health Services Administration (SAMHSA) in the US sponsors the Recovery Month to increase awareness about mental and substance use disorders and celebrate recovery. The organization also offers services to people with substance use disorders. Also, in countries such as India, government bodies provide financial assistance to many NGOs and urban local agencies to carry out combines services to spread awareness and rehabilitate individuals with addiction disorders.
Market Analysis and Insights: Global Addictions Therapeutics Market
The research report studies the Addictions Therapeutics market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Addictions Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Addictions Therapeutics Scope and Segment
The global Addictions Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Addictions Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Alcohol Addiction Therapeutics
Tobacco Addiction Therapeutics
Drug Addiction Therapeutics
by Application, this report covers the following segments
Public
Private
Government
Global Addictions Therapeutics market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Addictions Therapeutics key players in this market include:
Alkermes Plc
Amneal Pharmaceuticals Inc.
Indivior Plc
Johnson & Johnson Services Inc.
Mylan NV
Novartis AG
Novo Nordisk AS
Opiant Pharmaceuticals Inc.
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.
1 Market Overview of Addictions Therapeutics
1.1 Addictions Therapeutics Market Overview
1.1.1 Addictions Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Addictions Therapeutics Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Addictions Therapeutics Market Size by Region (2015-2026)
1.4 Global Addictions Therapeutics Historic Market Size by Region (2015-2020)
1.5 Global Addictions Therapeutics Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Addictions Therapeutics Market Size YoY Growth (2015-2026)
1.6.1 North America Addictions Therapeutics Market Size YoY Growth (2015-2026)
1.6.2 Europe Addictions Therapeutics Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Addictions Therapeutics Market Size YoY Growth (2015-2026)
1.6.4 Latin America Addictions Therapeutics Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Addictions Therapeutics Market Size YoY Growth (2015-2026)
2 Addictions Therapeutics Market Overview by Type
2.1 Global Addictions Therapeutics Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Addictions Therapeutics Historic Market Size by Type (2015-2020)
2.3 Global Addictions Therapeutics Forecasted Market Size by Type (2021-2026)
2.4 Alcohol Addiction Therapeutics
2.5 Tobacco Addiction Therapeutics
2.6 Drug Addiction Therapeutics
3 Addictions Therapeutics Market Overview by Application
3.1 Global Addictions Therapeutics Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Addictions Therapeutics Historic Market Size by Application (2015-2020)
3.3 Global Addictions Therapeutics Forecasted Market Size by Application (2021-2026)
3.4 Public
3.5 Private
3.6 Government
4 Global Addictions Therapeutics Competition Analysis by Players
4.1 Global Addictions Therapeutics Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Addictions Therapeutics as of 2019)
4.3 Date of Key Manufacturers Enter into Addictions Therapeutics Market
4.4 Global Top Players Addictions Therapeutics Headquarters and Area Served
4.5 Key Players Addictions Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Addictions Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Alkermes Plc
5.1.1 Alkermes Plc Profile
5.1.2 Alkermes Plc Main Business
5.1.3 Alkermes Plc Addictions Therapeutics Products, Services and Solutions
5.1.4 Alkermes Plc Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.1.5 Alkermes Plc Recent Developments
5.2 Amneal Pharmaceuticals Inc.
5.2.1 Amneal Pharmaceuticals Inc. Profile
5.2.2 Amneal Pharmaceuticals Inc. Main Business
5.2.3 Amneal Pharmaceuticals Inc. Addictions Therapeutics Products, Services and Solutions
5.2.4 Amneal Pharmaceuticals Inc. Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.2.5 Amneal Pharmaceuticals Inc. Recent Developments
5.3 Indivior Plc
5.5.1 Indivior Plc Profile
5.3.2 Indivior Plc Main Business
5.3.3 Indivior Plc Addictions Therapeutics Products, Services and Solutions
5.3.4 Indivior Plc Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.3.5 Johnson & Johnson Services Inc. Recent Developments
5.4 Johnson & Johnson Services Inc.
5.4.1 Johnson & Johnson Services Inc. Profile
5.4.2 Johnson & Johnson Services Inc. Main Business
5.4.3 Johnson & Johnson Services Inc. Addictions Therapeutics Products, Services and Solutions
5.4.4 Johnson & Johnson Services Inc. Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.4.5 Johnson & Johnson Services Inc. Recent Developments
5.5 Mylan NV
5.5.1 Mylan NV Profile
5.5.2 Mylan NV Main Business
5.5.3 Mylan NV Addictions Therapeutics Products, Services and Solutions
5.5.4 Mylan NV Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.5.5 Mylan NV Recent Developments
5.6 Novartis AG
5.6.1 Novartis AG Profile
5.6.2 Novartis AG Main Business
5.6.3 Novartis AG Addictions Therapeutics Products, Services and Solutions
5.6.4 Novartis AG Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.6.5 Novartis AG Recent Developments
5.7 Novo Nordisk AS
5.7.1 Novo Nordisk AS Profile
5.7.2 Novo Nordisk AS Main Business
5.7.3 Novo Nordisk AS Addictions Therapeutics Products, Services and Solutions
5.7.4 Novo Nordisk AS Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.7.5 Novo Nordisk AS Recent Developments
5.8 Opiant Pharmaceuticals Inc.
5.8.1 Opiant Pharmaceuticals Inc. Profile
5.8.2 Opiant Pharmaceuticals Inc. Main Business
5.8.3 Opiant Pharmaceuticals Inc. Addictions Therapeutics Products, Services and Solutions
5.8.4 Opiant Pharmaceuticals Inc. Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.8.5 Opiant Pharmaceuticals Inc. Recent Developments
5.9 Pfizer Inc.
5.9.1 Pfizer Inc. Profile
5.9.2 Pfizer Inc. Main Business
5.9.3 Pfizer Inc. Addictions Therapeutics Products, Services and Solutions
5.9.4 Pfizer Inc. Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.9.5 Pfizer Inc. Recent Developments
5.10 Teva Pharmaceutical Industries Ltd.
5.10.1 Teva Pharmaceutical Industries Ltd. Profile
5.10.2 Teva Pharmaceutical Industries Ltd. Main Business
5.10.3 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Products, Services and Solutions
5.10.4 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments
6 North America
6.1 North America Addictions Therapeutics Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Addictions Therapeutics Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Addictions Therapeutics Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Addictions Therapeutics Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Addictions Therapeutics Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Addictions Therapeutics Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
1.1 Addictions Therapeutics Market Overview
1.1.1 Addictions Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Addictions Therapeutics Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Addictions Therapeutics Market Size by Region (2015-2026)
1.4 Global Addictions Therapeutics Historic Market Size by Region (2015-2020)
1.5 Global Addictions Therapeutics Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Addictions Therapeutics Market Size YoY Growth (2015-2026)
1.6.1 North America Addictions Therapeutics Market Size YoY Growth (2015-2026)
1.6.2 Europe Addictions Therapeutics Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Addictions Therapeutics Market Size YoY Growth (2015-2026)
1.6.4 Latin America Addictions Therapeutics Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Addictions Therapeutics Market Size YoY Growth (2015-2026)
2 Addictions Therapeutics Market Overview by Type
2.1 Global Addictions Therapeutics Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Addictions Therapeutics Historic Market Size by Type (2015-2020)
2.3 Global Addictions Therapeutics Forecasted Market Size by Type (2021-2026)
2.4 Alcohol Addiction Therapeutics
2.5 Tobacco Addiction Therapeutics
2.6 Drug Addiction Therapeutics
3 Addictions Therapeutics Market Overview by Application
3.1 Global Addictions Therapeutics Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Addictions Therapeutics Historic Market Size by Application (2015-2020)
3.3 Global Addictions Therapeutics Forecasted Market Size by Application (2021-2026)
3.4 Public
3.5 Private
3.6 Government
4 Global Addictions Therapeutics Competition Analysis by Players
4.1 Global Addictions Therapeutics Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Addictions Therapeutics as of 2019)
4.3 Date of Key Manufacturers Enter into Addictions Therapeutics Market
4.4 Global Top Players Addictions Therapeutics Headquarters and Area Served
4.5 Key Players Addictions Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Addictions Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Alkermes Plc
5.1.1 Alkermes Plc Profile
5.1.2 Alkermes Plc Main Business
5.1.3 Alkermes Plc Addictions Therapeutics Products, Services and Solutions
5.1.4 Alkermes Plc Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.1.5 Alkermes Plc Recent Developments
5.2 Amneal Pharmaceuticals Inc.
5.2.1 Amneal Pharmaceuticals Inc. Profile
5.2.2 Amneal Pharmaceuticals Inc. Main Business
5.2.3 Amneal Pharmaceuticals Inc. Addictions Therapeutics Products, Services and Solutions
5.2.4 Amneal Pharmaceuticals Inc. Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.2.5 Amneal Pharmaceuticals Inc. Recent Developments
5.3 Indivior Plc
5.5.1 Indivior Plc Profile
5.3.2 Indivior Plc Main Business
5.3.3 Indivior Plc Addictions Therapeutics Products, Services and Solutions
5.3.4 Indivior Plc Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.3.5 Johnson & Johnson Services Inc. Recent Developments
5.4 Johnson & Johnson Services Inc.
5.4.1 Johnson & Johnson Services Inc. Profile
5.4.2 Johnson & Johnson Services Inc. Main Business
5.4.3 Johnson & Johnson Services Inc. Addictions Therapeutics Products, Services and Solutions
5.4.4 Johnson & Johnson Services Inc. Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.4.5 Johnson & Johnson Services Inc. Recent Developments
5.5 Mylan NV
5.5.1 Mylan NV Profile
5.5.2 Mylan NV Main Business
5.5.3 Mylan NV Addictions Therapeutics Products, Services and Solutions
5.5.4 Mylan NV Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.5.5 Mylan NV Recent Developments
5.6 Novartis AG
5.6.1 Novartis AG Profile
5.6.2 Novartis AG Main Business
5.6.3 Novartis AG Addictions Therapeutics Products, Services and Solutions
5.6.4 Novartis AG Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.6.5 Novartis AG Recent Developments
5.7 Novo Nordisk AS
5.7.1 Novo Nordisk AS Profile
5.7.2 Novo Nordisk AS Main Business
5.7.3 Novo Nordisk AS Addictions Therapeutics Products, Services and Solutions
5.7.4 Novo Nordisk AS Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.7.5 Novo Nordisk AS Recent Developments
5.8 Opiant Pharmaceuticals Inc.
5.8.1 Opiant Pharmaceuticals Inc. Profile
5.8.2 Opiant Pharmaceuticals Inc. Main Business
5.8.3 Opiant Pharmaceuticals Inc. Addictions Therapeutics Products, Services and Solutions
5.8.4 Opiant Pharmaceuticals Inc. Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.8.5 Opiant Pharmaceuticals Inc. Recent Developments
5.9 Pfizer Inc.
5.9.1 Pfizer Inc. Profile
5.9.2 Pfizer Inc. Main Business
5.9.3 Pfizer Inc. Addictions Therapeutics Products, Services and Solutions
5.9.4 Pfizer Inc. Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.9.5 Pfizer Inc. Recent Developments
5.10 Teva Pharmaceutical Industries Ltd.
5.10.1 Teva Pharmaceutical Industries Ltd. Profile
5.10.2 Teva Pharmaceutical Industries Ltd. Main Business
5.10.3 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Products, Services and Solutions
5.10.4 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Revenue (US$ Million) & (2015-2020)
5.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments
6 North America
6.1 North America Addictions Therapeutics Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Addictions Therapeutics Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Addictions Therapeutics Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Addictions Therapeutics Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Addictions Therapeutics Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Addictions Therapeutics Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
